Admission Document - BrainJuicer

cent. of the aggregate of the cash dividend and the tax credit. After taking account of the associated
tax credit, the additional liability equates to 25 per cent. of the cash dividend.
A corporate shareholder resident for tax purposes in the UK will not be chargeable to UK corporation
tax on any dividend received from the Company.
UK resident trustees of discretionary trusts are liable to income tax on UK company dividends at 32.5
per cent. of the gross dividend. After taking into account the 10 per cent. tax credit, the trustees will
be liable to additional income tax of 22.5 per cent. of the gross dividend, which is equal to 25 per cent.
of the net dividend.
The above is a general summary of certain tax reliefs which may be available and should not be
construed as constituting advice. Potential investors should obtain advice from their own investment
or taxation advisor before applying for any Placing Shares.
14. General
14.1 The total amount being raised by the Company through the Placing is £1.50 million. The estimated
amount of the expenses of the Placing, which are all payable by the Company, is approximately £0.49
million (including VAT). The net proceeds of the Placing will be approximately £1.01 million. Of the
Placing Price one pence represents the nominal value of each Ordinary Share and 107 pence
represents a premium.
14.2 Grant Thornton UK LLP of Byron House, Cambridge Business Park, Cowley Road, Cambridge
CB4 0WZ has given and not withdrawn its written consent to the inclusion in this document of
references to its name in the form and context in which it appears and its reports in Parts III and IV
of this document and accept responsibility for these reports for the purposes of the AIM Rules.
14.3 Teather & Greenwood Limited of Beaufort House, 15 St. Botolph Street, London EC3A 7QR has
given and not withdrawn its written consent to the inclusion in this document of references to its name
in the form and context in which they appear.
14.4 The financial information contained in this document does not constitute full statutory accounts as
referred to in section 240 of the Act.
14.5 The accounting reference date of the Company is 31 December.
14.6 There has been no significant change in the financial or trading position of the BrainJuicer UK Group
since 31 December 2005 being the date to which the last audited report and accounts of the
BrainJuicer UK Group were prepared.
14.7 There have been no interruptions in the Group’s business which may have or have had in the last 12
months a significant effect on the Group’s financial position.
14.8 The minimum amount which, in the opinion of the Directors, must be raised is approximately
£950,000 which will be applied towards the Placing and related expenses and as additional working
capital.
14.9 Save as disclosed in this document, no person (other than a professional adviser referred to in this
document or trade suppliers dealing with members of the Group) has:
(a)
(b)
received, directly or indirectly, from any member of the Group, within the twelve months
preceding the Company’s application for Admission; or
entered into any contractual arrangement (not otherwise disclosed in this document) to receive,
directly or indirectly, from any member of the Group on or after Admission,
any of the following:
(i)
fees totalling £10,000 or more;
81